With a one year PEG ratio of 919.88, Mesa Laboratories Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.02% of US stocks.
Price to trailing twelve month operating cash flow for MLAB is currently 43.89, higher than 90.48% of US stocks with positive operating cash flow.
The volatility of Mesa Laboratories Inc's share price is greater than that of merely 11.51% US stocks with at least 200 days of trading history.
Stocks that are quantitatively similar to MLAB, based on their financial statements, market capitalization, and price volatility, are ENV, AXTI, CUB, TEX, and AYX.
MLAB's SEC filings can be seen here. And to visit Mesa Laboratories Inc's official web site, go to www.mesalabs.com.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The company was founded in 1982 and is based in Lakewood, Colorado.
MLAB Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Mesa Laboratories Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Mesa Laboratories Inc ranked in the 33th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Mesa Laboratories Inc ended up being:
The business' balance sheet reveals debt to be 9% of the company's capital (with equity being the remaining amount). Approximately merely 22.6% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
As a business, Mesa Laboratories Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Technology), this tax rate is higher than merely 0% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
ITNM, CDNS, INOD, MEI, and FIS can be thought of as valuation peers to MLAB, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.
Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. Mesa Labs is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries. Mesa Labs offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary